What’s the Problem?
According to the U.S. Food & Drug Administration (FDA), this recall affects:
- Metformin HCl Extended Release Tablets, USP 500 mg — NDC 29033-055-01 — Lot Numbers MET100201 MET100401
The recalled metformin can be identified as an off-white oblong tablet debossed with “NM5”. These products were distributed Nationwide to wholesalers.
This recall was issued after it was found that the above lots of Nostrum metformin “… contain levels of nitrosamine impurities above the ADI limit of 96 ng/day as published in the FDA Guidance Document issued September, 2020,” according to the FDA.
If you were prescribed any metformin that is affected by this recall, you should contact your healthcare provider about obtaining a safe alternative treatment.
Do not stop taking metformin without talking to your doctor, as doing so could result in adverse health consequences.
This recall began on November 3, 2020.
Do I Have a Nostrum Metformin Lawsuit?
The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Nostrum Metformin Lawsuits. We are handling individual litigation nationwide and currently accepting new injury and death cases in all 50 states.
If you or a loved one was injured by a recalled metformin, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.